{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:18:24Z","timestamp":1791346704657,"version":"4.3.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:00:00Z","timestamp":1567728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12348-019-0183-x","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T14:04:42Z","timestamp":1567778682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Paradoxical reactions in ocular tuberculosis"],"prefix":"10.1186","volume":"9","author":[{"given":"Sudha K.","family":"Ganesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharanya","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridharan","family":"Sudharshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,6]]},"reference":[{"issue":"10","key":"183_CR1","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RM Houben","year":"2016","unstructured":"Houben RM, Dodd PJ (2016) The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med 13(10):e1002152","journal-title":"PLoS Med"},{"issue":"1","key":"183_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/09273948.2014.1004016","volume":"23","author":"ET Cunningham Jr","year":"2015","unstructured":"Cunningham ET Jr, Rathinam SR, Albini TA et al (2015) Tuberculous uveitis. Ocul Immunol Inflamm 23(1):2\u20136","journal-title":"Ocul Immunol Inflamm"},{"key":"183_CR3","unstructured":"WHO (2015) Global tuberculosis report (2015). World Health Organization"},{"issue":"5","key":"183_CR4","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.ajo.2008.06.011","volume":"146","author":"R Bansal","year":"2008","unstructured":"Bansal R, Gupta A, Gupta V et al (2008) Role of anti-tubercular therapy in uveitis with latent\/manifest tuberculosis. Am J Ophthalmol 146(5):772\u2013779","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"183_CR5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/bjophthalmol-2011-300209","volume":"96","author":"M Ang","year":"2012","unstructured":"Ang M, Hedayatfar A, Wong W, Chee SP (2012) Duration of antitubercular therapy in uveitis associated with latent tuberculosis: a case-control study. Br J Ophthalmol 96(3):332\u2013336","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"183_CR6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ajo.2013.11.013","volume":"157","author":"R La Distia Nora","year":"2014","unstructured":"La Distia Nora R, van Velthoven ME, Ten Dam-van Loon NH et al (2014) Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol 157(4):754\u2013761","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"183_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/eye.2010.235","volume":"25","author":"C Sanghvi","year":"2011","unstructured":"Sanghvi C, Bell C, Woodhead M et al (2011) Presumed tuberculous uveitis: diagnosis, management, and outcome. Eye (Lond) 25(4):475\u2013480","journal-title":"Eye (Lond)"},{"issue":"3","key":"183_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/bjophthalmol-2014-306474","volume":"100","author":"R Agrawal","year":"2016","unstructured":"Agrawal R, Gonzalez-Lopez JJ, Nobre-Cardoso J et al (2016) Predictive factors for treatment failure in patients with presumed ocular tuberculosis in an area of low endemic prevalence. Br J Ophthalmol 100(3):348\u2013355","journal-title":"Br J Ophthalmol"},{"key":"183_CR9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1378\/chest.114.3.933","volume":"114","author":"JW Chien","year":"1998","unstructured":"Chien JW, Johnson JL (1998) Paradoxical reactions in HIV and pulmonary TB. Chest 114:933\u2013993","journal-title":"Chest"},{"key":"183_CR10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1473-3099(05)70299-1","volume":"5","author":"DJ Nicolls","year":"2005","unstructured":"Nicolls DJ, King M, Holland D et al (2005) Intracranial tuberculomas developing while on therapy for pulmonary tuberculosis. Lancet Infect Dis 5:795\u2013801","journal-title":"Lancet Infect Dis"},{"key":"183_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10096-003-0998-z","volume":"22","author":"VC Cheng","year":"2003","unstructured":"Cheng VC, Yam WC, Woo PC et al (2003) Risk factors for development of paradoxical response during anti-tuberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis 22:597\u2013602","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"183_CR12","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1086\/427941","volume":"40","author":"CG Vidal","year":"2005","unstructured":"Vidal CG, Fernandez SR, Lacasa JM et al (2005) Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis 40:756\u2013759","journal-title":"Clin Infect Dis"},{"key":"183_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s10096-002-0821-2","volume":"21","author":"VC Cheng","year":"2002","unstructured":"Cheng VC, Ho PL, Lee RA et al (2002) Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 21:803\u2013809","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"183_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.survophthal.2007.08.015","volume":"52","author":"V Gupta","year":"2007","unstructured":"Gupta V, Gupta A, Rao NA (2007) Intraocular tuberculosis\u2014an update. Surv Ophthalmol 52:561\u2013587","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"183_CR15","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1136\/bjo.83.8.994","volume":"83","author":"J Biswas","year":"1999","unstructured":"Biswas J, Therese L, Madhavan HN (1999) Use of polymerase chain reaction in detection of Mycobacterium tuberculosis complex DNA from vitreous sample of Eales\u2019 disease. Br J Ophthalmol 83(8):994","journal-title":"Br J Ophthalmol"},{"key":"183_CR16","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1086\/429317","volume":"40","author":"CR Hawkey","year":"2005","unstructured":"Hawkey CR, Yap T, Pereira J et al (2005) Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis 40:1368\u20131371","journal-title":"Clin Infect Dis"},{"key":"183_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1164\/ajrccm.158.1.9712001","volume":"158","author":"M Narita","year":"1998","unstructured":"Narita M, Ashkin D, Hollender E, Pitchenik A (1998) Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 158:157\u2013161","journal-title":"Am J Respir Crit Care Med"},{"key":"183_CR18","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1097\/QAD.0000000000000311","volume":"28","author":"LA Chakrabarti","year":"2014","unstructured":"Chakrabarti LA, Boucherie C, Bugault F et al (2014) Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 28:1593\u20131602","journal-title":"AIDS"},{"key":"183_CR19","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/j.ijid.2008.11.005","volume":"13","author":"JA Park","year":"2009","unstructured":"Park JA, Park SS, Park SE (2009) A paradoxical reaction during antituberculosis therapy for congenital tuberculosis. Int J Infect Dis 13:e279\u2013e281","journal-title":"Int J Infect Dis"},{"issue":"4","key":"183_CR20","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0733-8635(05)70035-8","volume":"16","author":"PC van Voorst Vader","year":"1998","unstructured":"van Voorst Vader PC (1998) Syphilis management and treatment. Dermatol Clin 16(4):699\u2013711 xi","journal-title":"Dermatol Clin"},{"key":"183_CR21","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/eye.2008.204","volume":"23","author":"CM Cheung","year":"2009","unstructured":"Cheung CM, Chee SP (2009) Jarisch-Herxheimer reaction: paradoxical worsening of tuberculosis chorioretinitis following initiation of antituberculous therapy. Eye 23:1472\u20131473","journal-title":"Eye"},{"key":"183_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/eye.2013.5","volume":"27","author":"S Basu","year":"2013","unstructured":"Basu S, Nayak S, Padhi TR et al (2013) Progressive ocular inflammation following anti tubercular therapy for presumed ocular tuberculosis in a high endemic setting. Eye (Lond) 27:657\u2013662","journal-title":"Eye (Lond)"},{"issue":"8","key":"183_CR23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.4103\/ijo.IJO_184_17","volume":"65","author":"SK Ganesh","year":"2017","unstructured":"Ganesh SK, Ali BS (2017) Paradoxical worsening of a case of TB subretinal abscess with serpiginous-like choroiditis following the initiation of antitubercular therapy. Indian J Ophthalmol 65(8):761\u2013764","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"183_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/09273948.2014.943350","volume":"23","author":"T Yilmaz","year":"2015","unstructured":"Yilmaz T, Selcuk E, Polat N, Mutlu K (2015) Choroidal tuberculoma showing paradoxical worsening in a patient with miliary TB. Ocul Immunol Inflamm 23(1):97\u201399","journal-title":"Ocul Immunol Inflamm"},{"key":"183_CR25","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/eye.2010.110","volume":"24","author":"S Basu","year":"2010","unstructured":"Basu S, Das T (2010) Pitfalls in the management of TB-associated uveitis. Eye 24:1681\u20131684","journal-title":"Eye"},{"key":"183_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4274\/tjo.94809","volume":"46","author":"E Esen","year":"2016","unstructured":"Esen E, S\u0131zmaz S, Kunt Z, Demircan N (2016) Paradoxical worsening of tubercular serpiginous-like choroiditis after initiation of antitubercular therapy. Turk J Ophthalmol 46:186\u2013189","journal-title":"Turk J Ophthalmol"},{"issue":"00","key":"183_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09273948.2018.1489061","volume":"00","author":"R Agrawal","year":"2018","unstructured":"Agrawal R, Gunasekeran DV, Agarwal A et al (2018) The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational description of the spectrum of choroidal involvement in 245 patients with tubercular uveitis. Ocul Immunol Inflamm 00(00):1\u201311","journal-title":"Ocul Immunol Inflamm"},{"key":"183_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41433-018-0157-5","volume":"33","author":"A Agarwal","year":"2019","unstructured":"Agarwal A, Deokar A, Sharma R et al (2019) Longitudinal analysis of serum cytokine profile among patients with tubercular multifocal serpiginoid choroiditis: a pilot study. Eye 33:129\u2013135","journal-title":"Eye"},{"issue":"00","key":"183_CR29","first-page":"1","volume":"00","author":"K Aggarwal","year":"2017","unstructured":"Aggarwal K, Agarwal A, Deokar A et al (2017) Ultra-wide field imaging in paradoxical worsening of tubercular multifocal serpiginoid choroiditis after the initiation of anti-tubercular therapy. Ocul Immunol Inflamm 00(00):1\u20136","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"183_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/09273948.2016.1207785","volume":"24","author":"A Agarwal","year":"2016","unstructured":"Agarwal A, Aggarwal K, Deokar A et al (2016) Optical coherence tomography angiography features of paradoxical worsening in tubercular multifocal serpiginoid choroiditis. Ocul Immunol & Inflamm 24(6):621\u2013630","journal-title":"Ocul Immunol & Inflamm"},{"issue":"1","key":"183_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1378\/chest.120.1.193","volume":"120","author":"KA Wendel","year":"2001","unstructured":"Wendel KA, Alwood KS, Gachuhi R et al (2001) Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 120(1):193\u2013197","journal-title":"Chest"},{"issue":"6","key":"183_CR32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/COH.0000000000000502","volume":"13","author":"NF Walker","year":"2018","unstructured":"Walker NF, Stek C, Wasserman S et al (2018) The tuberculosis-associated immune reconstitution inflammatory syndrome: recent advances in clinical and pathogenesis research. Curr Opin HIV AIDS 13(6):512\u2013521","journal-title":"Curr Opin HIV AIDS"},{"key":"183_CR33","unstructured":"WHO Policy on Collaborative TB\/HIV Activities (2012): Guidelines for National Programmes and Other Stakeholders. Geneva: World Health Organization; 2012. ISBN-13: 978-92-4-150300-6."},{"issue":"5","key":"183_CR34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.4103\/0253-7613.117723","volume":"45","author":"JD Kapadia","year":"2013","unstructured":"Kapadia JD, Desai CK, Solanki MN et al (2013) Efficacy and safety of anti-tuberculosis drugs in HIV-positive patients: a prospective study. Indian J Pharmacol 45(5):447\u2013452","journal-title":"Indian J Pharmacol"},{"key":"183_CR35","doi-asserted-by":"crossref","unstructured":"Babu RB, Sudharshan S, Kumarasamy N et al (2006) Ocular tuberculosis in aquired immunodeficiency syndrome. Am J Ophthalmol:142\u2013413-418","DOI":"10.1016\/j.ajo.2006.03.062"},{"key":"183_CR36","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1097\/00126334-200412150-00007","volume":"37","author":"N Kumarasamy","year":"2004","unstructured":"Kumarasamy N, Chaguturu S, Meyer KH et al (2004) Incidence of immune reconstitution syndrome in HIV\/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India. J Acquir Immune Defic Syndr 37:1574\u20131576","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"183_CR37","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/sj.eye.6702662","volume":"21","author":"SR Rathinam","year":"2007","unstructured":"Rathinam SR, Lalitha P (2007) Paradoxical worsening of ocular tuberculosis in HIV patients after antiretroviral therapy. Eye (Lond) 21(5):667\u2013668","journal-title":"Eye (Lond)"},{"key":"183_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/archinte.162.1.97","volume":"162","author":"E Navas","year":"2002","unstructured":"Navas E, Martin-Davilla P, Moreno L et al (2002) Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch Intern Med 162:97\u201399","journal-title":"Arch Intern Med"},{"issue":"4","key":"183_CR39","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/COH.0b013e328302cc3d","volume":"3","author":"J Otiti-Sengeri","year":"2008","unstructured":"Otiti-Sengeri J, Meenken C, van den Horn GJ et al (2008) Ocular immune reconstitution inflammatory syndromes. Curr Opin HIV AIDS 3(4):432\u2013437","journal-title":"Curr Opin HIV AIDS"},{"issue":"11","key":"183_CR40","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/S0161-6420(01)01048-X","volume":"109","author":"E Zamir","year":"2002","unstructured":"Zamir E, Hudson H, Ober RR et al (2002) Massive mycobacterial choroiditis during highly active antiretroviral therapy: another immune-recovery uveitis? Ophthalmol 109(11):2144\u20132148","journal-title":"Ophthalmol"},{"issue":"11","key":"183_CR41","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1001\/archopht.116.11.1524","volume":"116","author":"PS Rosenbaum","year":"1998","unstructured":"Rosenbaum PS, Mbekeani JN, Kress Y (1998) Atypical mycobacterial panophthalmitis seen with iris nodules. Arch Ophthalmol 116(11):1524\u20131527","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"183_CR42","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4103\/0301-4738.27959","volume":"54","author":"S Mehta","year":"2006","unstructured":"Mehta S (2006) The treatment of ocular tuberculosis: a survey of published literature. Indian J Ophthalmol 54(4):278\u2013280","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"183_CR43","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.survophthal.2016.03.001","volume":"61","author":"AR Kee","year":"2016","unstructured":"Kee AR, Gonzalez-Lopez JJ, Al-Hity A et al (2016) Anti-tubercular therapy for intraocular tuberculosis: a systematic review and meta-analysis. Surv Ophthalmol 61(5):628\u2013653","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"183_CR44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/ICU.0b013e3282f06d2e","volume":"18","author":"KF Tabbara","year":"2007","unstructured":"Tabbara KF (2007) Tuberculosis. Curr Opin Ophthalmol 18(6):493\u2013501","journal-title":"Curr Opin Ophthalmol"},{"key":"183_CR45","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ajo.2018.03.032","volume":"190","author":"O Tomkins-Netzer","year":"2018","unstructured":"Tomkins-Netzer O, Leong B, Zhang X et al (2018) for the Sydney-London latent ocular TB study group (2018) Effect of antituberculous therapy on uveitis associated with latent tuberculosiS. Am J Ophthalmol 190:164\u2013170","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"183_CR46","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ajo.2011.05.004","volume":"152","author":"V Gupta","year":"2011","unstructured":"Gupta V, Bansal R, Gupta A (2011) Continuous progression of tubercular serpiginous-like choroiditis after initiating antituberculosis treatment. Am J Ophthalmol 152(5):857\u2013863","journal-title":"Am J Ophthalmol"},{"key":"183_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12348-015-0052-1","volume":"5","author":"RG Siantar","year":"2015","unstructured":"Siantar RG, Ho SL, Agrawal R (2015) Paradoxical worsening of tuberculous chorioretinitis in a Chinese gentleman. J Ophthalmic Inflamm Infect 5:21","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"6369","key":"183_CR48","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/bmj.286.6369.923","volume":"286","author":"WA McAllister","year":"1983","unstructured":"McAllister WA, Thompson PJ, Al-Habet SM et al (1983) Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed) 286(6369):923\u2013925","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"1","key":"183_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12348-016-0101-4","volume":"6","author":"A Fonollosa","year":"2016","unstructured":"Fonollosa A, Valsero S, Artaraz J et al (2016) Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis. J Ophthalmic Inflamm Infect 6(1):31","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"6","key":"183_CR50","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1080\/09273948.2017.1400074","volume":"26","author":"A Agarwal","year":"2018","unstructured":"Agarwal A, Handa S, Aggarwal K et al (2018) The role of dexamethasone implant in the management of tubercular uveitis. Ocul Immunol Inflamm 26(6):884\u2013892","journal-title":"Ocul Immunol Inflamm"},{"issue":"9","key":"183_CR51","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1097\/IAE.0b013e318285cdbe","volume":"33","author":"K Julian","year":"2013","unstructured":"Julian K, Langner-Wegscheider BJ, Haas A et al (2013) Intravitreal methotrexate in the management of presumed tuberculous serpiginous-like choroiditis. Retina 33(9):1943\u20131948","journal-title":"Retina"},{"key":"183_CR52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12348-016-0112-1","volume":"6","author":"S Jain","year":"2016","unstructured":"Jain S, Bajgai P, Tigari B et al (2016) Bevacizumab for paradoxical worsening treatment adjunct in HIV patient with choroidal tuberculoma. J Ophthalmic Inflamm Infect 6:42","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"12","key":"183_CR53","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1128\/JCM.05434-11","volume":"49","author":"AN Zeka","year":"2011","unstructured":"Zeka AN, Tasbakan S, Cavusoglu C (2011) Evaluation of the GeneXpert MTB\/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens. J Clin Microbiol 49(12):4138\u20134141","journal-title":"J Clin Microbiol"},{"key":"183_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2334-10-41","volume":"10","author":"H Albert","year":"2010","unstructured":"Albert H, Bwanga F, Mukkada S et al (2010) Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda. BMC Infect Dis 10:41","journal-title":"BMC Infect Dis"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-019-0183-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12348-019-0183-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-019-0183-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T23:05:30Z","timestamp":1599260730000},"score":1,"resource":{"primary":{"URL":"https:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-019-0183-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,6]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1186\/s12348-019-0183-x","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,6]]},"assertion":[{"value":"2 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed written consent was received for publication of the manuscript and figures. Written informed consent was obtained from the patient for publication of their individual details and accompanying images in this manuscript. The consent form is held by the authors\u2019 institution and is available for review by the Editor-in-Chief.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}